| ZAI LAB LTD ADR/10 |
| USA |
| Gesundheit |
| US98887Q1040 / A2DX1V |
| 1ZL (Frankfurt) / ZLAB (NASDAQ) |
| FRA:1ZL, ETR:1ZL, 1ZL:GR, NASDAQ:ZLAB |
| - |
| https://www.zailaboratory.. |
|
Zai Lab Ltd. is an innovative, commercial-stage biopharmaceutical company based in China and the United States. It focuses on discovering, developing, and commercializing transformative therapies that address significant unmet medical needs in oncolo..
>Volltext.. |
| 1894.84 Mio. EUR |
| 1405.1 Mio. EUR |
| 399.73 Mio. EUR |
| -178.51 Mio. EUR |
| -152.49 Mio. EUR |
| -1.39 EUR |
| 194.28 Mio. EUR |
| 675.36 Mio. EUR |
| -130.98 Mio. EUR |
| 1.9 |
| 15.59% |
| 31.5% |
| - |
| - |
| - |
| ZAI LAB ADR, ZAI LAB |
| 04.04.26 |
|